News from amgen A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

26 Jul, 2019, 21:00 BST Amgen Controls 98% Of The Shares In Nuevolution After The End Of The Extended Acceptance Period

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


08 Jul, 2019, 21:00 BST Amgen Announces The Outcome Of The Recommended Public Cash Offer To The Shareholders Of Nuevolution, Declares The Offer Unconditional And Completes The Offer

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


12 Jun, 2019, 14:17 BST Amgen Publishes Offer Document With Respect To The Recommended Public Cash Offer To The Shareholders Of Nuevolution

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


29 May, 2019, 07:00 BST Additional Irrevocable Undertakings To Accept Amgen's Recommended Public Cash Offer To The Shareholders Of Nuevolution

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


22 May, 2019, 07:40 BST Amgen announces a recommended public cash offer to the shareholders of Nuevolution

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be...


08 Aug, 2017, 07:00 BST Scottish Medicines Consortium Accepts Amgen's Multiple Myeloma Treatment, KYPROLIS® ▼ (carfilzomib), in Combination with Dexamethasone, for use at First Relapse

Carfilzomib Accepted in Combination with Dexamethasone Alone for the Treatment of Adult Patients with Multiple Myeloma who have Received At least One ...


13 Jun, 2017, 00:01 BST Amgen's Multiple Myeloma Treatment, KYPROLIS® (Carfilzomib), in Combination with Dexamethasone, Receives NICE Recommendation for Use at First Relapse

National Institute for Health and Care Excellence (NICE) Published a Final Appraisal Determination (FAD) in a Single Technology Appraisal Reviewing...


27 Apr, 2017, 15:33 BST NICE Recommends Amgen's BLINCYTO® ▼ (Blinatumomab) for Adults With Relapsed or Refractory Philadelphia Chromosome-Negative B-Precursor Acute Lymphoblastic Leukaemia

National Institute for Health and Care Excellence (NICE) Published a Final Appraisal Determination (FAD) in a Single Technology Appraisal Reviewing...


07 Mar, 2017, 13:05 GMT NICE Recommends Amgen's Vectibix® (panitumumab) for Metastatic Colorectal Cancer for Previously Untreated Patients

National Institute for Health and Care Excellence (NICE) Published a Final Appraisal Determination (FAD) in a Multiple Technology Appraisal (MTA)...


12 Feb, 2016, 00:01 GMT New Drug Treatment Kyprolis® ▼ (carfilzomib) for Relapsed Multiple Myeloma Launches in the UK

In a clinical trial, relapsed patients treated with carfilzomib in combination with lenalidomide and dexamethasone lived 8.7 months longer without...


01 Sep, 2015, 14:00 BST Cholesterol-Lowering Treatment Repatha®▼ (Evolocumab) Offers New Way To Help UK Patients

In people already using statins, new injection reduced "bad cholesterol" (low-density lipoprotein cholesterol, LDL-C) by between 55 and 75 per cent...


21 Jul, 2015, 12:08 BST European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha™ (evolocumab), The First PCSK9 Inhibitor To Be Approved In The World, For Treatment Of High Cholesterol

Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for Repatha™ (evolocumab), the first...


12 Nov, 2014, 14:00 GMT The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide

The Amgen Foundation today announced that the Amgen Scholars Program is expanding its presence with new host institutions in the U.S., Europe, and,...


17 Sep, 2014, 08:00 BST Amgen Foundation Commits €2 Million To Support Science Teachers Across Europe

The Amgen Foundation, in collaboration with European Schoolnet, has launched Amgen Teach, a three-year professional development initiative, designed...


09 May, 2013, 21:38 BST Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China

Amgen (NASDAQ:AMGN) and Zhejiang Beta Pharma Co., Ltd. (Zhejiang Beta Pharma) today announced that the companies have signed an agreement to form a...


10 Dec, 2012, 14:01 GMT Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics

Amgen (NASDAQ:AMGN) and deCODE Genetics today announced that the companies have entered into a definitive agreement under which Amgen will acquire...


28 Feb, 2012, 07:54 GMT Amgen and European Schoolnet Launch New Professional Development Initiative for Life Science Teachers

Program Will Help Increase Student Interest and Achievements in Science in France, Germany, Ireland and Poland Today, the Amgen Foundation and...


26 Jan, 2012, 14:36 GMT Amgen to Acquire Micromet

Acquisition Includes a Novel Cancer Treatment in Clinical Trials for Hematologic Malignancies Micromet's Proprietary BiTE® Platform has Potential to...


24 Jun, 2011, 16:39 BST Amgen Receives Positive CHMP Opinion for Vectibix® (Panitumumab) in Combination With Chemotherapy

Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...


10 Jun, 2011, 17:45 BST Amgen's Nplate(R) Rapidly Increased Platelet Counts in Adults With Primary ITP

- Interim Results From Largest Study Of Adult ITP Patients To Date Amgen today announced interim results from an international, single-arm study...


10 Jun, 2011, 08:00 BST New European Survey of ITP: Insight into Treatment Experience for Patients with Rare Blood Disorder

Amgen announced today the results of a new European survey of people suffering from a rare blood disorder called immune thrombocytopenia (ITP) shows...


09 Jun, 2011, 08:38 BST Amgen Launches First International Oncology Website

Amgen announced today the launch of its first oncology website for the international oncology community outside the United States....


20 May, 2011, 13:04 BST Amgen Receives CHMP Positive Opinion for XGEVA(TM) (Denosumab) in the European Union

Amgen (Nasdaq: AMGN) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...


08 Apr, 2011, 14:45 BST Amgen Establishes Commercial Operations in Brazil

Amgen (NASDAQ: AMGN), the world's largest biotechnology company, announced today the expansion of its operations in Brazil, including the acquisition ...


30 Mar, 2011, 22:46 BST Amgen to Appeal CHMP Opinion on Vectibix(R) (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe

Amgen (Nasdaq: AMGN) announced today that it has submitted a request to the European Medicines Agency (EMA) for a re-examination of the negative...